title: Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study.
abstract: BACKGROUND
  Hemoglobin (Hb) variability is a common occurrence in hemodialysis patients treated with erythropoiesis-stimulating agents. High amplitude fluctuations have been associated with greater risk of morbidity and mortality.
  
  
  METHODS
  This prospective, single centre pilot observational study was conducted over a 3-month period in daily practice patterns, to assess per-dialysis events and inter-dialysis complications that could interfere with erythropoiesis in patients undergoing hemodialysis.
  
  
  RESULTS
  Mean Hb levels remained stable in the 78 evaluable patients, as did darbepoetin alfa (DA) doses, including in patients suffering from diabetes or cardiac affections. In total, an average of 7.7 events / patient / month occurred, but no significant relationship with Hb excursions was shown.
  
  
  CONCLUSIONS
  The observation of 7.7 events per patient per month suggests a careful monitoring of Hb and DA dosing every other week, in order to maintain Hb level within the target.
authors.affiliation: Dialysis Unit, Diaverum Group, Clinique Mont Louis, 11, passage Courtois, 75011, Paris, France. jacques.rottembourg@wanadoo.fr.
authors.forename: Jacques B
authors.initials: JB
authors.lastname: Rottembourg
authors.forename: Floride
authors.initials: F
authors.lastname: Kpade
authors.forename: Fadia
authors.initials: F
authors.lastname: Tebibel
authors.forename: Aurélie
authors.initials: A
authors.lastname: Dansaert
authors.forename: Gaelle
authors.initials: G
authors.lastname: Chenuc
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000740:Anemia / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D015984:Causality; D015897:Comorbidity; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005602:France / Q000453:epidemiology; D006397:Hematinics / Q000008:administration & dosage; D006454:Hemoglobins / Q000032:analysis; D015994:Incidence; D010865:Pilot Projects; D006435:Renal Dialysis / Q000706:statistics & numerical data; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000453:epidemiology / Q000534:rehabilitation; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D000068256:Darbepoetin alfa; D004921:Erythropoietin; D006397:Hematinics; D006454:Hemoglobins